Meeting
2017 Genitourinary Cancers Symposium
Validation of a 17-Gene Genomic Prostate Score (GPS) as a predictor of biochemical recurrence (BCR) in men with prostate cancer treated with radical prostatectomy (RP) in a community setting.
Authors
Stephen K. VanDenEeden
Kaiser Permanente, Northern California, Oakland, CA
Stephen K. VanDenEeden , Nan Zhang , Charles P Quesenberry Jr., Jeong S Han , Amethyst D Leimpeter , Jun Shan , Athanasios C. Tsiatis , H. Jeffrey Lawrence , Phillip G. Febbo , Joseph C Presti Jr.
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 41)
DOI
10.1200/JCO.2017.35.6_suppl.41
Abstract #
41
Poster Bd #
C4
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
Genomic predictors of biochemical failure following radical prostatectomy.
First Author: Sanjay Aneja
Poster
2019 Genitourinary Cancers Symposium
A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.
First Author: Zachary Kornberg
Poster
2022 ASCO Genitourinary Cancers Symposium
Salvage radiotherapy (SRT) in combination with pembrolizumab in patients with PSA persistence or biochemical recurrence after radical prostatectomy due to prostate cancer.
First Author: Markus Grabbert
Poster
2021 ASCO Annual Meeting
Validation of the decipher genomic classifier (GC) in SAKK 09/10: A phase III randomized trial of dose-escalated salvage radiotherapy (SRT) after radical prostatectomy (RP).
First Author: Alan Dal Pra